Publications by authors named "Jonathan Dewhurst"

Claim this Profile
C
Commentary on Harding et al.: Responding to ketamine use disorder-Integrating practice, research, and whole-system approaches to harm reduction.
Rob Ralphs, Janine Day, Jonathan Dewhurst

Addiction· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial.
John Marsden, Mike Kelleher, Eilish Gilvarry, Luke Mitcheson, Jatinder Bisla, Jonathan Dewhurst

EClinicalMedicine· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone.
John Marsden, Mike Kelleher, Zoë Hoare, Dyfrig Hughes, Jatinder Bisla, Jonathan Dewhurst

Trials· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventing HIV infection among injecting drug users in high-risk countries: an assessment of the evidence.
Jonathan Dewhurst

AIDS Care· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis